Aspect Biosystems Overview

  • Founded
  • 2013

Founded
  • Status
  • Private

  • Employees
  • 77

Employees
  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 28

Aspect Biosystems General Information

Description

Operator of a biotechnology company intended to innovate at the intersection of biology, medicine, and engineering to build living human tissues. The company's platform offers proprietary microfluidic 3d bioprinting technology that creates advances in understanding fundamental biology, disease research, development of novel therapeutics, and regenerative medicine, enabling researchers to understand the creation of living, human tissues for medical research, therapeutic discovery, and regenerative medicine products.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
  • 1781 West 75th Avenue
  • Vancouver, British Columbia V6P 6P2
  • Canada
+1 (604) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aspect Biosystems Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Secondary Transaction - Private 000.00 Completed Generating Revenue
8. Later Stage VC (Series A) 01-Jun-2020 0000 000.00 Completed Generating Revenue
7. Grant 15-Nov-2018 00.00 00000 Completed Generating Revenue
6. Early Stage VC 15-Mar-2018 00000 00000 Completed Generating Revenue
5. Early Stage VC 31-Jul-2017 Completed Generating Revenue
4. Seed Round 01-Oct-2016 Completed Generating Revenue
3. Seed Round 30-Jun-2015 Completed Startup
2. Grant 01-Sep-2014 $50.3K Completed Startup
1. Accelerator/Incubator 01-Nov-2013 Completed Startup
To view Aspect Biosystems’s complete valuation and funding history, request access »

Aspect Biosystems Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of a biotechnology company intended to innovate at the intersection of biology, medicine, and engineering to bu
Biotechnology
Vancouver, Canada
77 As of 2022
000.00
000000 - 000 000.00

000000

olor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore mag
0000000000000
Schlieren, Switzerland
00 As of 0000
000.00
000000000 000.00

000000

g elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam,
0000000000000
Villaz-Saint-Pierre, Switzerland
00 As of 0000
000000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Aspect Biosystems Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
InSphero Formerly VC-backed Schlieren, Switzerland 00 000.00 000000000 000.00
0000000 Venture Capital-Backed Villaz-Saint-Pierre, Switzerland 00 000000000000
00000000 Formerly VC-backed San Diego, CA 00 000.00 000000&0
000000 0000000000 Venture Capital-Backed Austin, TX 0 00.000 000000000000 00.000
0000000000 Venture Capital-Backed Westminster, CO 000 00000 00000000000 00000
You’re viewing 5 of 8 competitors. Get the full list »

Aspect Biosystems Patents

Aspect Biosystems Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3156774-A1 Systems and methods for printing a core shell fiber Pending 01-Nov-2019 0000000000
EP-4051487-A1 Systems and methods for printing a core shell fiber Pending 01-Nov-2019 0000000000
US-20210370590-A1 Systems and methods for printing a core fiber Pending 19-Sep-2018 0000000000
CA-3112940-A1 Systems and methods for printing a core fiber Pending 19-Sep-2018 0000000000
EP-3853003-A1 Systems and methods for printing a core fiber Pending 19-Sep-2018 B29C64/209
To view Aspect Biosystems’s complete patent history, request access »

Aspect Biosystems Executive Team (13)

Name Title Board Seat Contact Info
Tamer Mohamed Co-Founder, Chief Executive Officer, President & Board Member
Raymond Smith Chief Financial Officer
Samuel Wadsworth Ph.D Co-Founder & Chief Scientific Officer
Simon Beyer Ph.D Co-Founder, Chief Product Officer & Chief Technology Officer
Eric Roos Chief Business Development Officer
You’re viewing 5 of 13 executive team members. Get the full list »

Aspect Biosystems Board Members (9)

Name Representing Role Since
Andrew Haughian Pangaea Ventures Board Member 000 0000
Christopher Bissonnette Ph.D Pallasite Ventures Board Member 000 0000
Devyn Smith Ph.D Self Board Member 000 0000
Don Haut Aspect Biosystems Board Member 000 0000
Konrad Walus Ph.D Aspect Biosystems Co-Founder & Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Aspect Biosystems Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aspect Biosystems Investors (28)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Darcy Hughes Angel (individual) Minority 000 0000 000000 0
Erik Peterson Angel (individual) Minority 000 0000 000000 0
Hedgewood Asset Manager Minority 000 0000 000000 0
Hein Brand Angel (individual) Minority 000 0000 000000 0
Jawad Nabulsi Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 28 investors. Get the full list »